Artículos del autor

solaci

Femoropopliteal

Should We Start Stenting with DES in Femoropopliteal Territory?

Percutaneous intervention of femoropopliteal lesions have been the standard strategy these past two decades. The development of...
solaci -
Institutional News

Survey to Evaluate Myocardial Infarction Reperfusion in LatAm

The Latin American Society of Interventional Cardiology together with the Interamerican Society of Cardiology (SIAC) and the...
solaci -
Coronary disease

ACC 2022 – EDIT-CMD

Roughly 40% of patients receiving a coronary angiography for stable angina (angina episodes twice a week despite...
solaci -
Acute coronary syndromes

ACC 2022 – Complete Trial QoL: Complete Revascularization in STEMI

The COMPLETE study has shown complete revascularization in STEMI reduces cardiovascular mortality or new AMI, which generated...
solaci -
Pharmacology

ACC 2022 | VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM Eligible for Septal Reduction Therapy

Roughly 50% of hypertrophic cardiomyopathies (HCM) are obstructive, and of this percentage, most of symptoms can be...
solaci -
Pharmacology

ACC 2022 – POISE-3: Tranexamic Acid, Bleeding and Cardiovascular Events in Non-Cardiac Surgeries

Tranexamic Acid is an antifibrinolytic which has been shown to reduce bleeding in orthopedic patients and cardiac...
solaci -
Institutional News

April 7th | Medtronic-SOLACI Masterclass with Gregg Stone: Revascularization in Patients with Multivessel Lesions

Join us in the third Medtronic-SOLACI masterclass with Dr. Gregg Stone (USA) and renowned Latin-American panelists. In this...
solaci -
Institutional News

19/04 – Cusp Overlap Masterclass with International and LATAM Guests

What is the rationale behind the cusp overlap technique? How should we combine it with commissural alignment...
solaci -